Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boersma

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
MMWR. Morbidity and Mortality Weekly Report|March 30, 2023
JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023Lauren E Owens, Dustin W Currie, Ellen A Kramarow, et al.
Clinical Chemistry|August 1, 1997
Point: status of lipid and lipoprotein standardizationJ R McNamara, E T Leary, F Ceriotti, et al.
Molecular Cancer|November 19, 2015
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathwayMarijn T M van Jaarsveld, Patricia F van Kuijk, Antonius W M Boersma, et al.
Plos One|May 8, 2019
MicroRNAs as possible indicators of drug sensitivity in breast cancer cell linesKatharina Uhr, Wendy J C Prager-van der Smissen, Anouk A J Heine, et al.
Oncogene|October 10, 2012
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cellsM T M van Jaarsveld, J Helleman, A W M Boersma, et al.
Molecular Oncology|January 28, 2014
DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivityMarijn T M van Jaarsveld, Maikel D Wouters, Antonius W M Boersma, et al.
Breast Cancer Research : BCR|April 23, 2013
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAsMuhammad Riaz, Marijn T M van Jaarsveld, Antoinette Hollestelle, et al.
British Journal of Cancer|August 24, 2013
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumoursC M M Gits, P F van Kuijk, M B E Jonkers, et al.
International Journal of Cancer|December 31, 2013
MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressorsCaroline M M Gits, Patricia F van Kuijk, Moniek B E Jonkers, et al.
Nature|August 26, 2021
Chromatic periodic activity down to 120 megahertz in a fast radio burstInés Pastor-Marazuela, Liam Connor, Joeri van Leeuwen, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
MMWR. Morbidity and Mortality Weekly Report|March 30, 2023
JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023Lauren E Owens, Dustin W Currie, Ellen A Kramarow, et al.
Clinical Chemistry|August 1, 1997
Point: status of lipid and lipoprotein standardizationJ R McNamara, E T Leary, F Ceriotti, et al.
Molecular Cancer|November 19, 2015
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathwayMarijn T M van Jaarsveld, Patricia F van Kuijk, Antonius W M Boersma, et al.
Plos One|May 8, 2019
MicroRNAs as possible indicators of drug sensitivity in breast cancer cell linesKatharina Uhr, Wendy J C Prager-van der Smissen, Anouk A J Heine, et al.
Oncogene|October 10, 2012
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cellsM T M van Jaarsveld, J Helleman, A W M Boersma, et al.
Molecular Oncology|January 28, 2014
DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivityMarijn T M van Jaarsveld, Maikel D Wouters, Antonius W M Boersma, et al.
Breast Cancer Research : BCR|April 23, 2013
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAsMuhammad Riaz, Marijn T M van Jaarsveld, Antoinette Hollestelle, et al.
British Journal of Cancer|August 24, 2013
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumoursC M M Gits, P F van Kuijk, M B E Jonkers, et al.
International Journal of Cancer|December 31, 2013
MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressorsCaroline M M Gits, Patricia F van Kuijk, Moniek B E Jonkers, et al.
Nature|August 26, 2021
Chromatic periodic activity down to 120 megahertz in a fast radio burstInés Pastor-Marazuela, Liam Connor, Joeri van Leeuwen, et al.
Pageof 4